Positive News SentimentPositive NewsNASDAQ:NUTX Nutex Health (NUTX) Stock Price, News & Analysis → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free NUTX Stock Alerts $0.10 0.00 (-3.92%) (As of 01:21 PM ET) Add Compare Share Share Today's Range$0.10▼$0.1050-Day Range$0.10▼$0.1952-Week Range$0.09▼$1.10Volume550,100 shsAverage Volume1.81 million shsMarket Capitalization$65.74 millionP/E RatioN/ADividend YieldN/APrice Target$1.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Nutex Health alerts: Email Address Nutex Health MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside908.1% Upside$1.00 Price TargetShort InterestHealthy0.34% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.31 out of 5 starsMedical Sector470th out of 939 stocksBusiness Services, Not Elsewhere Classified Industry56th out of 90 stocks 3.5 Analyst's Opinion Consensus RatingNutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.00, Nutex Health has a forecasted upside of 908.1% from its current price of $0.10.Amount of Analyst CoverageNutex Health has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.34% of the float of Nutex Health has been sold short.Short Interest Ratio / Days to CoverNutex Health has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutex Health has recently decreased by 5.16%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNutex Health does not currently pay a dividend.Dividend GrowthNutex Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NUTX. Previous Next 3.3 News and Social Media Coverage News SentimentNutex Health has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Nutex Health this week, compared to 1 article on an average week.Search Interest7 people have searched for NUTX on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nutex Health insiders have not sold or bought any company stock.Percentage Held by Insiders48.48% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.32% of the stock of Nutex Health is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutex Health is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutex Health is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutex Health has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaAltcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) About Nutex Health Stock (NASDAQ:NUTX)Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.Read More NUTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUTX Stock News HeadlinesMarch 18, 2024 | investorplace.com3 Promising Penny Stocks You Can Pick Up for Less Than a QuarterMarch 15, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Announces Preliminary 2023 Headline Financials And Provides Update On The Timing Of Its 10-k FilingMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 15, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILINGFebruary 23, 2024 | benzinga.comNutex Health Stock (NASDAQ:NUTX), Analyst Ratings, Price Targets, PredictionsFebruary 5, 2024 | msn.comNutex Health's Medicare Advantage membership doublesFebruary 5, 2024 | finance.yahoo.comNUTEX HEALTH ANNOUNCES OVER 100% INCREASE IN MEDICARE ADVANTAGE ENROLLMENTJanuary 31, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Announces Streamlined Strategic PlanMarch 28, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…January 30, 2024 | finance.yahoo.comNUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLANJanuary 23, 2024 | markets.businessinsider.comNutex Prices Direct Offering, Stock Plummets In Pre-marketJanuary 23, 2024 | finance.yahoo.comNutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and WarrantsJanuary 18, 2024 | finance.yahoo.comNutex Health Inc.'s (NASDAQ:NUTX) top owners are retail investors with 47% stake, while 43% is held by insidersDecember 18, 2023 | finance.yahoo.comNUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENovember 27, 2023 | markets.businessinsider.comNutex Health Targets To Regain Compliance With Minimum Bid Price Requirement On Or Before May 20November 27, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTNovember 24, 2023 | morningstar.comNutex Health Inc NUTXNovember 24, 2023 | finance.yahoo.comThomas Vo Spends US$114k On Nutex Health StockNovember 11, 2023 | finance.yahoo.comEven With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance CompletelyNovember 11, 2023 | finance.yahoo.comInvestors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price JumpNovember 10, 2023 | finanznachrichten.deNutex Health, Inc.: Nutex Health Reports Third Quarter 2023 Financial ResultsNovember 10, 2023 | msn.comNutex Health GAAP EPS of -$0.01, revenue of $62.7MNovember 9, 2023 | finance.yahoo.comNUTEX HEALTH REPORTS THIRD QUARTER 2023 FINANCIAL RESULTSNovember 1, 2023 | finance.yahoo.comNutex Health Chairman and CEO Tom Vo to Speak on Panel at Upcoming Danaher Summit on DiagnosticsSeptember 20, 2023 | finance.yahoo.comNUTEX HEALTH ANNOUNCES PARTICIPATION IN THE 2023 CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCESeptember 13, 2023 | thestreet.comNutex Health Inc.September 9, 2023 | finance.yahoo.comChairman of the Board & CEO of Nutex Health Thomas Vo Buys More StockSee More Headlines Receive NUTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:NUTX CUSIPN/A CIK1479681 Webwww.nutexhealth.com Phone(713) 660-0557Fax631-670-6780Employees1,150Year FoundedN/APrice Target and Rating Average Stock Price Target$1.00 High Stock Price Target$1.00 Low Stock Price Target$1.00 Potential Upside/Downside+880.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-424,780,000.00 Net Margins-12.48% Pretax Margin-11.49% Return on Equity-26.11% Return on Assets-6.51% Debt Debt-to-Equity Ratio2.70 Current Ratio1.34 Quick Ratio1.30 Sales & Book Value Annual Sales$219.29 million Price / Sales0.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / Book0.54Miscellaneous Outstanding Shares670,780,000Free Float345,587,000Market Cap$68.42 million OptionableNot Optionable Beta0.46 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Thomas T. Vo M.B.A. (Age 51)M.D., Chairman of the Board & CEO Comp: $938.23kDr. Warren Hosseinion M.D. (Age 52)President & Director Comp: $937.66kMr. Jon C. Bates CPA (Age 53)M.B.A., Chief Financial Officer Comp: $299.46kMs. Pamela W. Montgomery B.S.N. (Age 58)J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Secretary Comp: $275.36kMs. Elisa Michael Luqman Esq. (Age 60)J.D., M.B.A., Chief Legal Officer (SEC) & Board Secretary Comp: $251.33kMr. Joshua DeTillio FACHEM.B.A., Chief Operating OfficerMs. LaChoenda RosalesDirector of AccountingLaTanya BrackensDirector of ComplianceMs. Vivian Sanders M.B.A.Director of MarketingSarah WallaceDirector of Human ResourcesMore ExecutivesKey CompetitorsAugmedixNASDAQ:AUGXAmerican WellNYSE:AMWLGenenta ScienceNASDAQ:GNTAInflaRxNASDAQ:IFRXvTv TherapeuticsNASDAQ:VTVTView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 137,505 shares on 3/11/2024Ownership: 1.888%Beaird Harris Wealth Management LLCBought 630,168 shares on 2/27/2024Ownership: 0.139%GSA Capital Partners LLPBought 203,658 shares on 2/16/2024Ownership: 0.076%Vanguard Group Inc.Sold 137,505 shares on 2/15/2024Ownership: 1.888%Northern Trust CorpSold 144,363 shares on 2/13/2024Ownership: 0.102%View All Insider TransactionsView All Institutional Transactions NUTX Stock Analysis - Frequently Asked Questions Should I buy or sell Nutex Health stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NUTX shares. View NUTX analyst ratings or view top-rated stocks. What is Nutex Health's stock price target for 2024? 1 Wall Street research analysts have issued twelve-month price targets for Nutex Health's shares. Their NUTX share price targets range from $1.00 to $1.00. On average, they predict the company's share price to reach $1.00 in the next twelve months. This suggests a possible upside of 908.1% from the stock's current price. View analysts price targets for NUTX or view top-rated stocks among Wall Street analysts. How have NUTX shares performed in 2024? Nutex Health's stock was trading at $0.18 at the start of the year. Since then, NUTX shares have decreased by 44.9% and is now trading at $0.0992. View the best growth stocks for 2024 here. When is Nutex Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024. View our NUTX earnings forecast. Who are Nutex Health's major shareholders? Nutex Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (1.89%), Vanguard Group Inc. (1.89%), Truist Financial Corp (0.65%), GDS Wealth Management (0.17%), Beaird Harris Wealth Management LLC (0.14%) and Northern Trust Corp (0.10%). Insiders that own company stock include John J Waters, Joshua Detillio, Michael Lee Reed, Pamela W Montgomery and Thomas T Vo. View institutional ownership trends. How do I buy shares of Nutex Health? Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NUTX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.